| Original language | English |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | Expert Review of Cardiovascular Therapy |
| Volume | 23 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - 10 Feb 2025 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?
- Anouk Achten
- , Steven A. Muller*
- , Peter Paul Zwetsloot
- , Michelle Michels
- , Peter van der Meer
- , Hans L.A. Nienhuis
- , Manon G. van der Meer
- , Vanessa P.M. van Empel
- , Marish I.F.J. Oerlemans
- , Christian Knackstedt
*Corresponding author for this work
- Maastricht University
- University Medical Centre Utrecht
- Johns Hopkins University
- University Medical Centre Groningen
- Utrecht University
- European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart)
Research output: Contribution to journal › Editorial › Academic › peer-review
3
Citations
(Scopus)
18
Downloads
(Pure)